Eli Lilly & Co. (LLY)
Current
- (-)
After Hours
Rating Performance
Rating Return
-3.51% vs
Rating Accuracy
50.0% (1 of 2*)
Rating Return
-3.51% vs
Rating Accuracy
50.0% (1 of 2*)
Rating Return
-3.51% vs
Rating Accuracy
50.0% (1 of 2*)
Rating Return
+25.25% vs
Rating Accuracy
50.0% (1 of 2*)
FV Performance
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
-19.07%
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
-19.39%
FV Accuracy
0 Hits (0% Hit Rate)
FV Avg. Distance
-19.39%
FV Accuracy
3 Hits (6.98% Hit Rate)
FV Avg. Distance
-1.28%
*There is a current rating on the stock that is included in these numbers based on its performance so far
About
CEO
David A. Ricks
Employees
33,625
Industry
Diversified Biopharmaceuticals
Sector
Healthcare
Headquarters
Indianapolis
Exchange
New York Stock Exchange
Website
http://www.lilly.comSummary Stats
Market Cap
314B
Revenue
29.2B
Net Income
6.03B
EPS
$6.66
Price-to-Earnings
49.66
Price-to-Book
31.2
Debt-to-Equity
3.71
News
Analyst Ratings
Price targets projected by 15 analysts
High
$200.00
Average
$168.80
Low
$143.00
Ratings calculated by 18 analysts
Buy
10
Hold
8
Sell
0
Last Dividend
Amount
$0.98
Dividend Date
Frequency
quarterly
Dividend Yield
Earnings
Most Recent Earnings
Last Earnings for Q4 2022
Above by $0.31
$2.09 +17.4%
1.78
2.49
Down 16%
Actual vs Estimates
XX
xxx
Upcoming Estimates Unavailable
-
-
-
--